GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Hicin Pharmaceutical Co Ltd (SZSE:300584) » Definitions » Market Cap

Nanjing Hicin Pharmaceutical Co (SZSE:300584) Market Cap : ¥1,917.6 Mil (As of Jun. 05, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Nanjing Hicin Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nanjing Hicin Pharmaceutical Co's share price for the quarter that ended in Mar. 2024 was ¥17.8. Nanjing Hicin Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 120.0 Mil. Therefore, Nanjing Hicin Pharmaceutical Co's market cap for the quarter that ended in Mar. 2024 was ¥2,136.0 Mil.

Nanjing Hicin Pharmaceutical Co's quarterly market cap increased from Sep. 2023 (¥2,768.4 Mil) to Dec. 2023 (¥2,793.6 Mil) but then declined from Dec. 2023 (¥2,793.6 Mil) to Mar. 2024 (¥2,136.0 Mil).

Nanjing Hicin Pharmaceutical Co's annual market cap increased from Dec. 2021 (¥2,400.0 Mil) to Dec. 2022 (¥3,864.0 Mil) but then declined from Dec. 2022 (¥3,864.0 Mil) to Dec. 2023 (¥2,793.6 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nanjing Hicin Pharmaceutical Co's Enterprise Value for Today is ¥2,193.5 Mil.


Nanjing Hicin Pharmaceutical Co Market Cap Historical Data

The historical data trend for Nanjing Hicin Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Hicin Pharmaceutical Co Market Cap Chart

Nanjing Hicin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,379.20 2,462.40 2,400.00 3,864.00 2,793.60

Nanjing Hicin Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,968.80 2,691.60 2,768.40 2,793.60 2,136.00

Competitive Comparison of Nanjing Hicin Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Nanjing Hicin Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanjing Hicin Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanjing Hicin Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Nanjing Hicin Pharmaceutical Co's Market Cap falls into.



Nanjing Hicin Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Nanjing Hicin Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥23.28*120
=¥2,793.6

Nanjing Hicin Pharmaceutical Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥17.8*120
=¥2,136.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Hicin Pharmaceutical Co  (SZSE:300584) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Nanjing Hicin Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Nanjing Hicin Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Hicin Pharmaceutical Co (SZSE:300584) Business Description

Traded in Other Exchanges
N/A
Address
Heng Road 1, Nanjing Economic and Technological Development Zone, Jiangsu Province, Nanjing, CHN, 210009
Nanjing Hicin Pharmaceutical Co Ltd is a China-based company engaged in producing pharmaceutical preparations. In addition, it is also involved in manufacturing synthetic chemicals, conducting new drug research and development as well as technical transferring. The company produces series of the medicines such as antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for the cardio-cerebral system and immuno-modulate agents. The active pharmaceutical ingredients, omeprazole sodium for injection, cefepime hydrochloride for Injection and lansoprazole tablets are exported by the firm into South-Asian countries, South-American countries and European countries.
Executives
Cao Yu Ping Directors, executives
Yan Mei Qiang Directors, executives
Jiang Xiang Ming Executives
Gu Hai Independent director

Nanjing Hicin Pharmaceutical Co (SZSE:300584) Headlines

No Headlines